Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Pheochromocytoma 1Pain, Intractable 1Obesity 1Non-functioning Pituitary Adenoma 1Neoplasms 1Nausea 1Intrathecal Dexmedetomidine 1Dyspnea 1Delirium 1Death 1

Interventions

Dexamethasone 12Palonosetron 11Aprepitant 11Ondansetron 8Olanzapine 5Calcium Dobesilate 4netupitant 2fosaprepitant 2Tropisetron 2Radiotherapy 2Fluorouracil 2yangzheng xiaoji 1rolapitant 1ramosetron 1niraparib 1netupitant, palosentron drug combination 1nabiximols 1isatuximab 1ginger extract 1dolasetron 1casopitant 1Yoga 1Therapeutics 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Paclitaxel 1Oxaliplatin 1Octreotide 1Midazolam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Nausea × Dexmedetomidine × Clear all
NCT01687751 2015-05-25

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

Fraser Health

Phase 2 Withdrawn
Other

Death, Delirium, Dyspnea, Nausea, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡